Osteoarthritis Trial, Recruiting NCT06686680 Sponsor: Spaulding Rehabilitation Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06686680
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a previous ACL (knee ligament) reconstruction surgery using tissue from their own body or a donor, and who now have a form of arthritis in that knee as a result
  • People who had their ACL reconstruction surgery at least one year ago
  • People between the ages of 18 and 55
  • People whose main source of pain is coming from the knee
  • People who have been diagnosed with post-traumatic osteoarthritis (a type of arthritis that develops after a joint injury) confirmed by a doctor using imaging such as an X-ray
  • People who score 85 or lower on at least 2 out of 4 areas (pain, symptoms, daily activities, or quality of life) on a standard knee health questionnaire called the KOOS
  • People who do not have mechanical symptoms that would prevent them from completing the study activities (confirm with trial site)

Who may not be able to join:

  • People who have received any injections into the knee joint within the past 3 months
  • Women who are currently pregnant or planning to become pregnant during the study period
  • People who have a nerve condition (neuropathy) that affects their ability to feel pain
  • People with a known heart condition that could be affected by shockwave therapy
  • People with chronic conditions such as rheumatological diseases, immune system disorders, connective tissue disorders (for example, Ehlers-Danlos Syndrome), or active cancer that are known to affect inflammation or that require ongoing use of immune-modifying medicines taken by mouth or through a drip — note that asthma managed with inhalers only is not an exclusion
  • People who are currently using oral steroids or anti-inflammatory medicines at the time of joining the trial
  • People who have had ACL injuries or reconstruction surgery in both knees, or who have had revision (repeat) ACL surgery
  • People whose cancer is not yet in remission, or who have been in remission for fewer than five years
  • People who have previously received shockwave therapy (the treatment being studied in this trial) for knee osteoarthritis
  • People who have a pacemaker, bone screws, or any other metal implants that would prevent them from having an MRI scan or receiving shockwave therapy
  • People who do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (617) 952-6800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Spaulding Rehabilitation Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Knee Injury and Osteoarthritis Outcome Score (KOOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov